Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab?
Amat, Flore
Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab? [electronic resource] - Expert review of respiratory medicine 06 2018 - 475-482 p. digital
Publication Type: Journal Article; Review
1747-6356
10.1080/17476348.2018.1475233 doi
Anti-Asthmatic Agents--economics
Asthma--drug therapy
Biomarkers--metabolism
Cell Adhesion Molecules--metabolism
Cell Count
Child
Cost-Benefit Analysis
Eosinophil Cationic Protein--metabolism
Eosinophil-Derived Neurotoxin--metabolism
Eosinophils--metabolism
Exhalation
Humans
Inflammation--metabolism
Nitric Oxide--metabolism
Omalizumab--economics
Phenotype
Sputum--metabolism
Biomarkers for severe allergic asthma in children: could they be useful to guide disease control and use of omalizumab? [electronic resource] - Expert review of respiratory medicine 06 2018 - 475-482 p. digital
Publication Type: Journal Article; Review
1747-6356
10.1080/17476348.2018.1475233 doi
Anti-Asthmatic Agents--economics
Asthma--drug therapy
Biomarkers--metabolism
Cell Adhesion Molecules--metabolism
Cell Count
Child
Cost-Benefit Analysis
Eosinophil Cationic Protein--metabolism
Eosinophil-Derived Neurotoxin--metabolism
Eosinophils--metabolism
Exhalation
Humans
Inflammation--metabolism
Nitric Oxide--metabolism
Omalizumab--economics
Phenotype
Sputum--metabolism